Aadi Global holds exclusive rights for products of pharmaceutical excipient and API manufacturers for North & South America & the EU. The excipients (superdisintegrants) that can be made available include Sodium Starch Glycollate, Croscarmellose Sodium, Polacrillin Potassium, Calcium carboxymethylcellulose to name a few. We also formulate and distribute Nutraceuticals and some select intermediates like 4-dimethyl amino benzaldehyde, 4-dimethylamino cinnamaldehyde, indicator chemicals for laboratory use.
AbbVie Contract Manufacturing has a portfolio of state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. For more than 30 years, AbbVie Contract Manufacturing has offered contract manufacturing services that spans biologics, potent, drug product, prefilled syringes, fermentation, as well as selling high quality
active pharmaceutical ingredients (APIs).
Shanghai Acebright Pharmaceuticals Group Co Ltd was founded in 1996. More than 12 GMP standard manufacturing sites located in China and India. Focus on a serial of Vitamin products, ARV APIs & intermediates, and oncology APIs & FPPs, etc. Integrated CDMO service partner from R&D to commercial manufacturing.
AGC Chemicals belongs to AGC Inc., a world-leading producer of glass, chemicals, electronic materials and ceramics. AGC Chemicals is a fluorine specialist, active in CDMO custom chemical synthesis & the production and development of APIs & intermediates, all in compliance with GMP. Continuous improvement is key within AGC.
Agno Pharma is a global pharmaceutical contract research and manufacturing organization (CRO & CMO). Agno Pharma engages in the research, development, manufacturing, sourcing, marketing and distribution of chemically and biologically derived pharmaceutical intermediates, APIs, nutraceuticals, and fine chemicals. Agno Pharma is a fully integrated company with in-house business development, R&D, manufacturing and regulatory compliance capabilities. Agno Pharma is your strategic CRO & CMO for your drug discovery, development, and commercialization.
Aktin Chemicals, Inc. is a professional researcher and manufacturer of phytochemicals or natural compounds at semi-commercial and industrial scales. Our regular inventory includes Betulin, Betulinic acid, Triptolide, Celastrol, Ursolic Acid, Cepharanthine to more than 700 compounds. We also offer custom isolation, impurity isolation, semi-synthesis services and CRO services. We are proud to be innovative researchers and manufacturers of standardized botanical extracts and isolated pure compounds serving the dietary supplement, cosmetic and pharmaceutical industries worldwide.
AAI Pharma Services Corp. and Cambridge Major Laboratories, Inc. have joined to form Alcami, a world class supplier of comprehensive pharmaceutical development and manufacturing services. With seven sites across the globe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services.
About Almac Group
‘Partnering to Advance Human Health'
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown for 50 years and now employs in excess of 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
AmbioPharm Inc (API) is a full-service peptide manufacturing company headquartered at our cGMP peptide manufacturing facility in North Augusta, S.C. In our cGMP manufacturing facility in Shanghai, China, we manufacture peptides at very large scales, provide pilot manufacturing and process development, and manufacture raw materials, building blocks, and custom peptides. Our two cGMP facilities are capable of handling any manufacturing scale to produce bulk peptides to custom specifications using a wide-range of skill sets in solid and solution-phase chemistry. In addition to manufacturing peptides, we also perform organic conjugations of peptides to proteins, toxoids, antifungals, KLH, and PEG.
Amoli Organics Pvt. Ltd., India Is a leading pharmaceutical manufacturer and exporter of API's & Intermediates established 25 years ago. Amoli has 2 manufacturing sites approved by WHO GMP, USFDA, EDQM/EU GMP , PMDA(Japan), TGA (Australia), ANVISA(Brazil) and COFEPRIS(Mexico). We offer APIs covering Anti- Inflammatory, Anti-Hyperlipidemic , Anti- Depressant,Anti-Diabetic, Anti-Convulsant , Anti- Fungal & Vitamin API's. Our key products are Diclofenac Salts, Atorvastatin Calcium and Rosuvastatin. Company's R&D center spread over 12000 sq ft. is engaged in developing in-house process technology for APIs. Amoli's APIs have excellent acceptability globally. Amoli has good presence in more than 85 countries including India.
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more twenty-five years. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Solutions (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing (DPM). Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API supports the chemical development and cGMP manufacture of complex API, including potent, controlled substances, biologics, peptides, steroids, hormones, cytotoxic compounds and sterile API. DPM supports development through commercial scale production of complex liquid-filled and lyophilized parenterals, sterile suspensions and ophthalmic formulations.
Angelini Pharma has a cGMP facility, inspected by US FDA since 1979, and by all international regulatory aothorities. Speciaized in Custom synthesis of API's and Advanced Intermediated, equipped with a Class C (10,000) kilo lab and four production units.
Angelini Fine Chemicals Plants is specialized in Costum's Synthesis of API's and Advanced Intermediates. It has 140.000 Lt gasslined and Stainless steel Reactor Capacity and a Pilot plant with 250 -800 Lt reactor capacity. Multipurpose technology base, full analytical services and support, blending and sieving. Flow Reactors allowing new syntheses heretofore not possible, increase yields, product quality, scalability and efficiency of Chemical processing, reducing the performance variability and costs.
Leader in the wellness industry, a point of reference in the field of health protection, Angelini is the natural choice for daily wellbeing.
Angelini manufactures, markets and distributes products for personal health and wellbeing.
Angelini is an "integrated company" with extensive research, development, manufacture and marketing of active ingredients, and equivalent branded drugs, medical products and dietary supplements. At the international level, Angelini is concentrated in the areas of analgesia and inflammation, neuropsychiatry, flu, diseases of the oral cavity, gynecology, personal hygiene and disinfection.
The most well-known international brands are Trittico, Tantum and Aulin. Locally, Angelini is focused on specific areas thanks to the strength of its brands.
In Italy, Angelini is one of the first pharmaceutical companies and specializes mainly in analgesia and inflammation, neuropsychiatry, influenza and diseases of the oral cavity, gynecology and disinfection.
It is also present with a line of generic drugs (Angenerico) that includes about 60 molecules.
Anhui Biochem United Pharmaceutical Co Ltd (ABUP) is a leading Hi-Tech enterprise that specializes in research, production and marketing of anti-HIV and anti-HBV chiral drugs in China. It was formed in 2007 by Anhui Biochem Pharmaceutical that was established in 2003, and QVT Fund. ABUP is located in Taihe Country, Fuyang City, Auhui Province. It has more than four hundred staff members with a total asset of over RMB 510 million, covering an area of 50.74 acres.
ABUP masters international core technology of chiral drugs and has one of biggest production and most complete variety of anti-HBV and anti-HIV/AIDS API manufacturing base in China, which starts the precedent of domestic anti-HBV and anti-HIV products and ends the history of a long term of dependence on import antiviral. ABUP has two owned subsidiaries: Anhui Biochem Bio-Pharmaceutical Co., Ltd. and Anhui Biochem Medical Sales Co., Ltd. It has formed a complete industry chain from API R&D, synthesis to formulation production and marketing. ABUP insists on independent research and development, and maintains close relationships with many domestic universities and research institutes. Meanwhile, it introduces new varieties of anti-HBV/HIV drugs. At present, ABUP has most of the AIDS antiviral "cocktail" drugs, such as Lamivudine, Zidovidine, Nevirapine, Tenofovir Disoproxil Fumarat, Emtricitabine, Efavirenz and their intermediates. ABUP also has Lamivudine, Enticavir and Tenofovir Disoproxil Fumarat. These drugs are most effective anti-HBV drugs in the world. Besides, our products also contain digestant Lafutidine and antidepressant Selegiline Hydrochloride Capsules. China ChemPharm Brand Summit nominated ABUP as the "2011 Top Ten Brand of Innovation Chempharm Enterprise" on April 21, 2011. Good reputation, efficient management and quality products, make the company's products export to international and domestic markets. ABUP has got the registration certificate of Canada, India, Russia and Brazil and other countries, and will carry out the U.S. FDA, EU and WHO on-site audit. ABUP will finally achieve the vision of "Respect life; Stop HBV &HIV/AIDS" by tightly grasping the historic opportunities of development, adhering to the objective of the company and sticking to the mission of the company.
We are one of leading producers and exporters of Paracetamol API and Paracetamol DC worldwide and contract manufacturer of Paracetamol Finish Dosage, Health Ingredients and Healthcare Products,
We can offer Paracetamol API (with COS & EDQM cGMP approval, US FDA DMF Filing and annual capacity of 24000 tons), Paracetamol DC (with Germany Government of Upper Bavaria cGMP approval, US FDA DMF Filing and annual capacity of 5000 tons), Paracetamol Finish Dosage (with oversea authority cGMP approval and annual capacity of 8 billion tablets), and ISO14001 ISO9001 OHSAS18001 Approval and EHS Certification.
APIRx Pharmaceuticals B.V. is a leading pharmaceutical company dedicated to manufacturing of natural cannabinoid API's (Active Pharmaceutical Ingredients), which are extracted from cannabis plant material and purified to pharma grade. All manufacturing stages are performed under cGMP conditions. The following cannabinoids are in our product portfolio: Tetrahydrocannabinol (THC or Delta-9THC) Cannabidiol (CBD) Cannabigerol (CBG) APIRx also uses its own API's for the development of new Rx and OTC drugs, nutraceuticals, cosmeceuticals and other products.
We are Ardena, a reputable contract partner delivering drug development, manufacturing, logistics and (bio)analytical services to pharmaceutical customers globally. In parallel, we work with you to compile your regulatory dossier and to fast track your product towards compliance. Every day, we guide companies through the hurdles and challenges of drug development. Our integrated service offering helps to streamline the drug's progress to clinic and beyond. Ardena is your one source contractor for the chemical and pharmaceutical development of your valued compounds. In parallel, we provide you with full product analytical and bioanalytical support during development. Our dossier centric approach makes a difference. We work with you to compile your regulatory dossier in parallel with drug development, saving you time, identifying hurdles and fast tracking your product to compliance. We are experts in writing and formatting supporting CMC documentation.
ATABAY Group of companies: A leader in the production of Paracetamol (Acetaminophen) powder and direct compression grades in its FDA USA-approved and EU, back integrated and dedicated cGMP plant. Back integration covers production of p-aminophenol which is acetylated to Paracetamol and re-crystallized with water as solvent.
Products conform to the current BP, USP, PH EUR pharmacopeias and has COS from EDQM.
Atabay provdies an injectable form of Paracetamol and produces a wide-range of pharmaceutical drugs such as beta-lactam antibiotics, analgesics, antirheumatics, antituberculosis products in tablets, suppositories, syrup, suspension, cream/ointment and sachet dosage forms. Atabay is currently developing generic antiviral drugs with in-house synthesized APIs.
Aurisco is an innovative company dedicated to developing and manufacturing pharmaceutical chemicals serving pharmaceutical companies worldwide. With 2 manufacturing sites for chemistry synthesis & fermentation, all of which are operated according to cGMP standards, Aurisco offers Active Pharmaceutical ingredients (APIs especially in segments of Steroids, Oncology, Anti-Virus and etc.) and drug intermediates as well as contract developing and manufacturing of pharmaceutical chemicals from kilos to tons.
Auro Laboratories Limited is manufacturing generic API's with corporate office located at Mumbai and the manufacturing facility located at Tarapur, Maharashtra, India. We have Certificate of Suitability(COS) for Metformin Hydrochloride and Chlorphenamine Maleate. Manufacturing facility has EUGMP and WHO-GMP certification.API Products manufactured: Metformin Hydrochloride, Glibenclamide, Glimepiride, Glipizide, Chlorphenamine Maleate, Chlorzoxazone.
Avanti Polar Lipids Inc is the world leader for lipids of unparalleled purity. The company manufactures products for the Research Chemist and cGMP lipids for Pharmaceutical Production. These include phospholipids, sphingolipids, detergents, sterols, polymers, bioactive lipids, chelators plus new Fluorescent and Deuterated lipids. Recent developments include unique Detergents, Adjuvants, Glycosylated Sphingolipids and Kdo2 Lipid A - an Endotoxin replacing LPS. Avanti is the licensed manufacturer of mass spectrometry standards to the LIPID MAPS Initiative. Avanti's extensive Lipid Analysis Department handles Identity Testing, Bioanalytical Lipid Assay and cGLP & 21CFR, part 11 Compliant Analysis. Avanti's clients include the Pharmaceutical & Nutraceutical Industries and Lipid Researchers.
Avara offers contract manufacturing of APIs, solid and liquid sterile drug product, and packaging from nine world-class facilities. Led by highly experienced industry veterans, Avara understands clients' individual needs and focuses on providing an exceptional outsourcing experience by delivering on commitments in terms of scope, schedule, compliance and price.
Your Ingredients Partner. From Source to Solution.
A leading provider of ingredients, Barentz is all about adding value for customers, from source to solution. Our chemists and pharmaceutical ingredients experts support our customers in making the right ingredients choices for their new and existing products. With its heritage and focus on the European market, Barentz is also rapidly growing in the Middle East, Asia Pacific and Americas. The turnover for the Barentz group reached 1 billion euro in 2016, serving some 15.000 customers in over 60 countries with 900 employees. Barentz also provides ingredients to the personal care, food and nutrition and animal nutrition industries.
Baxter International Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services.
BCN Peptides is focused on the GMP manufacture of synthetic peptides API's for pharmaceutical and veterinary application. We manufacture from R&D to commercial quantities of generic peptides and NCE's. Our state of the heart facility is fully GMP, US FDA and EMEA approved.
Biddle Sawyer is a full-service distributor and manufacturer's representative of specialty and fine chemicals, API's and drug products. We source and custom develop/manufacture non-GMP and cGMP intermediates, API's, AI's, drug products and pharmaceutical excipients with over 60 years' experience, with a sales and market focus on the NAFTA region. Biddle Sawyer has global reach with headquarters in New York, offices in Shanghai and Buenos Aires, and representation in India. Strong supply relationships with manufacturers in the U.S., Japan, Finland, China, Taiwan and India allow for an expansive offering of small molecules for various markets including Pharma, Ag, Polymers, Electronics, Beauty Care, Flavor/Fragrance, etc. Our full line of cellulose-based GMP excipients manufactured by two major Japanese companies also allows for formulation options and technical assistance in formulation development.
Biological E Limited established in 1953, leading manufacturer of Human vaccines Tetanus, DT, DTP, Td HepatitisB, DTP-HepB-Hib Pentavalent, Hib, IPV, Japanese encephalitis, Measles and Rubella, Tetanus Antitoxin and Snake Antivenin. Attained WHO prequalification for Tetanus, DTPHepBHib, JE, DTP and Td. APIs – Noscapine Base and HCL (Alkaloids) and Heparin Sodium. Pipeline Injectables - Heparin Inj, LMWH Enoxaparin, Dalteparin, Fosaprepitant, Daptomycin, Risperidone and Paliperidone Palmitate.
BioVectra is a contract development and manufacturing organization that serves pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs). An innovative and reliable partner with a strong quality history, BioVectra has over 45 years of experience specializing in:
- Microbial Fermentation
- Complex Chemistry
- High-Potency APIs
- Process & Analytical Development
- Drug Development
C-squared PHARMA is a Luxembourg-based pharmaceutical group established in 2014 (www.c2pharma.com) which manufactures and distributes its Active Pharmaceutical Ingredients (“APl”) and complex chemical compounds from phytochemical and chemical origins. The current API product portfolio includes: Atropine, Digoxin, Homatropine, Pilocarpine, N-Butylbromide Scopolamine / Hyoscine (SNBB) and reaches more than 100 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, Africa and Australia. C-squared PHARMA also offers customized cold-chain logistics solutions through its specialized affiliate Logistics4Pharma(www.logistics4pharma.com) as well as R&D-scale synthesis services of complex organic molecules and impurities through its affiliate ASM Research Chemicals (www.asm-research-chemicals.de). C-squared PHARMA is a key sponsor of the “Partnership for a Better World” program that ensures a sustainable, traceable & fair-trade harvesting and sourcing of phytochemical and botanicals used for pharmaceutical APIs such as Pilocarpine. The program sustains of more than 1,000 families and contributes to the preservation of the Brazilian biodiversity.
We are a global leader with 100 years experience in the research, development and manufacturing of high-grade activated carbon as purification aid in the pharmaceutical and other industries. Our powdered, granular and extruded activated carbons are used for the removal of colors, odors, by-products, traces of catalyst or any other impurities that aren't allowed in the final product. Under the NORIT® brand we produce medicinal products based on activated carbon including contract manufacturing. We meet the most stringent quality requirements that guarantee consistency in performance and purity. Our specialists can support you selecting the best activated carbon for your process in the early drug development phase, scaling up and full production.
Cambrex is an
innovative life sciences company that provides pharmaceutical products,
expertise and technologies that accelerate small molecule therapeutics into
markets across the world. With over 35 years of API
development and manufacturing expertise, Cambrex is tried and trusted across
branded and generic API markets.
Cambridge Isotope Laboratories Inc is the world leader in the manufacture and separation of stable isotopes and stable isotope labeled compounds. CIL offers an array of highly pure compounds that are uniformly or selectively enriched in 13C, 15N, D, 18O or 17O. CIL offers over 15,000 stable-isotope labeled products for use as internal standards and in synthetic applications, including the manufacturing of APIs. CIL maintains one of the only privately held (non-governmental) D2O re-enrichment facilities at our isotope separation facility to further ensure continuous supply of D2O for manufacturing. CIL's capabilities range from milligram to multi-kilogram of deuterated reagents and intermediates. In addition, cGMP suites for manufacturing clinical trial grade materials (CTM) are also available.
BioServices is a global provider of high-quality services in the field of
custom microbial process development and manufacturing. We offer dedicated
solutions for proteins, (high-value) small molecules and microorganisms for
applications in pharma, food, feed and bio-industrial markets.
We are the largest, independent, beta-lactam free microbial contract manufacturing facility in Europe. Our facility is located near Naples, in the south of Italy and has a total fermentation capacity of about 1400 m3 which is spread over two separate fermentation areas. Our associated downstream processing capabilities are spread between multiple, isolated recovery and purification plants with a large diversity of unit operations capable of handling multiple projects in parallel. Recently, we have significantly expanded our spray-drying capabilities, up to pharma API grade.
For more than 50 years, we have built a track record based on our extensive experience in working with a variety of bacterial, yeast and fungal systems. We offer our development and manufacturing services from lab (2-15 L), to pilot (3 m3) to industrial scale (3 m3 - 100 m3).
We have dedicated areas for pharmaceutical manufacturing as well as food-grade manufacturing and comply to cGMP (FDA and EMA approved), GFSI (FSSC 22.000) and ISO standards (14001). Our teams operate on a 24-hour, 7-days/week schedule throughout the year.
Founded in 2001, Caregen is a global leader of research and marketing of Biomimetic Peptides and Growth Factors. Caregen is not only the company to register Growth Factors in PCPC (Personal Care Products Council, formerly CTFA) but also possesses various Biomimetic Peptide patents all around the world. At Caregen, we value innovations and ideas. With highly skilled in-house scientists and marketing specialists with years of experience in developing and manufacturing of innovative active ingredients, we offer a sophisticated line of purified Biomimetic Peptides and Growth Factors at affordable prices, which is made possible from our mass production technology, enabling our current and prospective customers to have the advantages that they always needed. Additionally, we offer customized Biomimetic Peptides and toll manufacturing services that will provide our customers the solution to their research and manufacturing challenges.
Catalyst + Talent
Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing results.
We serve thousands of innovators, large and small, in over 100 markets, including 36 of the top 50 biotech companies and 49 of the top 50 pharmaceutical companies. Our team of over 1,000 talented scientists supports 40% of recent new drug approvals, and our nearly 30 global sites make or package over 100 billion units annually. Our significant intellectual property in oral, injectable, and respiratory dosage forms and advanced drug packaging includes over 1,200 patents and patent applications.
CCPIT Sub-council of Chemical Industry and CCOIC Chemical Industry Chamber of Commerce are the branch organizations of CCPIT and CCOIC. They belong to China Petroleum and Chemical Industry Federation (CPCIF) and work as the CPCIF Conference and Exhibition Department. CCPIT Sub-council of Chemical Industry is a certified member of UFI and Shanghai Convention & Exhibition Industries Association (SCEIA).
We aim to promote trade, economic and technological cooperation between foreign countries and China. Based on serving the entire chemical industry and our member companies, we will make the best efforts to promote the development of chemical industry.
Organizing exhibitions and conferences is our main channel of promoting domestic and overseas economic and trade exchange, however, we organize domestic enterprises to go abroad, hosting and participating in professional chemical industry exhibitions.
Central Glass Germany is dedicated to process development, upscaling and production of active ingredients and intermediates for the pharmaceutical and cosmetics industry. It operates a FDA
and EU inspected facility in Halle-Kuensebeck. An experienced and highly skilled team of organic chemists and support functions, such as analytical specialists and QA/QC team, ensure success and high quality of our projects.
Our service offering includes:
- Process Development and upscaling from grams to tons.
- Custom synthesis for pre-clinical studies, Phase I-III trials and launch.
- cGMP production of commercial APIs and Intermediates.
- In-process and finished API analytical methods development.
- Validation of manufacturing processes and analytical methods.
- ICH stability studies for registration.
- Comprehensive support for CMC file preparation.
Changsha Huir (CSHR) has been dedicated to the research and development of herbal and nutraceutical ingredients.
we are a Pre-listed professional herbal extracts and APIs manufacturer with Five Plants in China, Three Warehouses in USA(CA,NY,FL), One warehouse in Europe.Certificates: Organic| ISO 9001:2008| Kosher| Halal| HACCP| FDA| FSSC22000 (addmitted to GFSI) Production license registered.Main Herbal Extract:Ginkgo Biloba PE| Resveratrol| Milk Thistle PE| GSH (L-Glutathione Reduced)| Huperzine A| L-dopaNaringin| Hesperidin| Diosmin| Diosmetin| Genistein| Nomilin| Limonnin Lycopene| Curcumin| Chlorophyllin (Cu, Mg, Fe)Stevia PE| Monk fruit PE| NHDCRutin| Quercetin| Genistein| Sophoricoside Berberine HCL| St John's Wort PE| Tongkat Ali PE| Ginseng PE| St John' Wort PE| 5-HTP| Olive leaf PE| Rhodiola Rosea PE| PhytosterolEssential oils like Perillaldehyde 60%-98%, Perillartine 99% and CLA (oil and beadlets powder)...Our main API and Pharmaceutical intermediates:1Vinpocetine 99%2Galantamine Hydrobromide Lycoremine 99%3Orlistat 99%White powder96829-58-24Octopamine Hcl (DL-Octopamine hydrochloride) 99%White powder770-05-85Pyridoxal 5-phosphate monohydrate 99%Light yellow to yellow powder41468-25-16Evodiamine 98%White powder518-17-273-indolylcarbinol (Indole-3-carbinol) 99%White powder700-06-183,3'-Diindolylmethane (3,3'-Methylenebisindole| DIM) 99%White powder1968/5/49Melatonin 99%White powder73-31-410L-Theanine (Theanine| N-ethyl-L-glutamine) 99%White powder3081-61-6
Email: [email protected] Tel: 001-9093202087 What's App: 0086-13142188019Skype: vivianxie1314 Wechat: vivianxie86
Changzhou Sunlight Pharmaceutical Co., Ltd. (SunlightPharma) is located in
Benniu Town, Changzhou City, Jiangsu Province, China. It is close to the
Beijing-Shanghai High-Speed Railway, Shanghai-Nanjing Expressway, and Changzhou
Airport via convenient transportation. SunlightPharmawas founded in 1990.Its
campus covers a total area of 369,580?. Both of
its Changzhou API andIntermediateProduction Site and Changzhou Pharmaceutical
Formulation Production Site are located in BenniuBiomedical Industry Park.
ItsJiangsu Sunlight Pharmaceutical and Chemical Material Co., Ltd. is located
in the National Development Zone-Jiangsu CoastalIndustrial Park.
SunlightPharma is a national High-Tech enterprise. It is a Jiangsu AAA Credit Enterprised, Outstanding Scientific and technological Enterprised company.It is also recognized as a progressive and environmentalyfriendly company. The company consists of the R&D Division, the Manufacturing Division and the Sales Division. It has already been certified by the ISO 9001:2008 Quality Management System,the ISO 14001:2004 Environmental Management System, and OHSAS 18001 Occupational Health and Safety Management System.SunlightPharma hasalready obtained the Chinese Pharmaceutical Manufacturing Permit which allows the company to produce pharmaceutical chemical intermediates, APIs and finished products. With 80% of our products being exported to international markets such as the USA, Europe, and Southeast Asia, SunlightPharma has built a steady cooperative relationship with hundreds of clients, including top 500 enterprises. We have already passed the audits by EDQM, USFDA and Chinese GMP for our APIs, and have gotten boththe COS certificate and EUGMP certificate.
SunlightPharmacuttently has over 500 employees, including some foreign experts, and graduates from European, American, Russian, Japanese, Korean and Indian universities.Our R&D center has an excellent R&D team consisting of PhDs, professorsand senior engineers. We have already obtained 59 patents in China. We have the leading technology of Catalytic Hydrogenations, Reductive Alkylations, Chiral Resolutions, High-Pressure Reactions, and Cryogenic Reactions in China.Our Formulation R&D Laboratory is equipped with advanced instruments, which can fulfill the R&D tasks for both general solid dosage forms and sustained-and-controlled release solid dosage forms.
SunlightPharma owns modern manufacturing workshops for API and Oral Solid Formulations, which are designed and constructed in accordance with the national safety standards and GMP requirements. The API Workshop is fully equipped with reactors with volume ranging from 100L to 6000L, temperature ranging from-78°C to 300°C, and the pressure up to 12.5MPa. The Oral Solid FormulatonWorkshop is equipped with granulation linkage lines, fully automatic clean air conditioning system, and a purified water preparation system. It can produce tablets, capsules, and granules simultaneously to meet customers' demands for custom-manufactured products.
We have already imported and installed advanced analytical instruments from America and Japan. These instruments include LC-MS, GC-MS, GC, HPLC, UPLC, FT-IR, UV/VIS, AA, automatic KFmeters as well as automatic titrators.
Our modern warehouse of raw materials and finished products is managed under the ERP management system. We also havea dedicated warehouse controlling the temperature and humidity at storage. SunlightPharma has the highest commitments for environmental protection.We have already built two 8500m³ waste water treatment and purifying sites, so as to guarantee the company's sustainable development and provide stable service to our customers.
SunlightPharma committed ourselves to "Create benefits for customers,Create prosperity for society,Create futures for employees,Create value for shareholders" and "Promote health for mankind" with the mind set of “ Quality, Serive, and Reputation First”. We will keep continuing to provide the highest quality products and service for our clients and society.
Chemi SPA has
relevant expertise in the area of Low Molecular Weight Heparins,
Polysaccharide Derivatives, Peptides and Oncology Products.
Pipeline of several technology-innovative products and generic Finished Dosage Forms with granted Marketing Authorizations and dossiers available for licensing
Chemport Inc. was established in 2001 and has been a leading Omega-3 fatty acid manfuacturer with our own high technology.
We are capable of producing up to 97% of EPA, 95% of DHA, and 95% of EPA & DHA blends omega-3 fish oil.
We are one of the extremly few capable companines in the world which can supply two FDA approved prescribed fish oil drus, Omega-3 Acid Ethyl Esters called Lovaza and Omacor and EPA min. 96% called Vascepa along with high concentrated fish oil supplements.
Chemtrade is the only North American manufacturer of API grade KCl. Our potassium chloride product is supplied globally and is available in Custom morphologies (spheres and cubes) for sustained release or immediate release application. Chemtrade's KCl is currently compliant with USP/EP/FCC/JP/BP and ACS monographs. Chemtrade also manufactures high purity compendial grade (NF/BP/JP/EP/FCC and ACS) KOH and NaOH pellets which are used as excipients for pH adjustment and buffers. Additionally Chemtrade is one of the largest North American manufacturer of aluminum based adjuvants for vaccines and plasma protein separation.
Chengdu Pukang Biotechnology Co., Ltd. was founded in 2008, is a high-tech enterprise specializing in unnatural amino acids and their derivatives. The company has established a R & D center with 1000 square meters and a production base of 12000 square meters. The quality system is managed according to the GMP standard. The main products of the company are Lifitegrast intermediate ,Semaglutide series,N-heterocyclic butane series, hydroxyproline series derivatives,PEG derivation and other unnatural amino acids derivatives. Over the past 10 years, the company has provided over120 kinds of compounds for more than 40 pharmaceutical companies and over 100 agents in the world, providing high quality technical services for the development of new drugs and the development of generic drugs. Adhering to the “Quality first, Technology leading” business philosophy, we provide the best products and the best service for the global customers.
Yacht Bio-Tech Co Ltd is a R&D and process improvement company for bio-medicines. We are mainly engaged in new drugs research, process improvement, drug structural analysis, products quality, and establishing the standards of products. Our fields refer to anti-tumor, anti-infective, cardiovascular, and immune system drugs. Also in the field of technical research and product development, we are able to enlarge the production from laboratory scale to pilot plant scale. By now, we provide optimum technical service from laboratory production/scale to pilot plant scale. In same cases, we even provide the small commercial scale.
Our main focus is on the field of developing microbe and synthetic chemicals, doing innovative research in partial synthesis of antibiotic new drugs, products and technics, and also doing research in sreening new drugs from microbe. We combine genetic engineering technics with tranditional technics, which is used for breeding strains in antibiotics from microbe. We also develop engineering bacteria and heterozyme that is used for microbes and enzyme transformation in drug research. We are also specialized in immobilization technology that is used in the micro-cells or enzyme of important pharmaceutical intermediates transformation or synthesis and resolution in chiral-compound. We choose optimum technics in important antibiotics manufacture. We have gained satisfactory achievement in partial antibiotic synthesis tehnics, microstrains by using modern technics, production technique, and bilocatalysis technology used in manufacturing chiral pharmaceutical intermediates. Ever since establishment, Yacht achieved the major breakthroughs in key technics of important drugs, in which the innovation research project CLVA (New biosynthetical technique for high-production of Clavulanic acid) was funded by Inno-Fund of Chinese Science and Technology Association, new technics of reduction drug Orlistat and antibiotic Daptomycin, and fermentation and extraction technics of cephalosporin C. All technics mentioned above have been transferred to enterprises in China and abroad, which makes Yacht gain a high reputation. Besides, our high quality API products are well sold in USA and EU. Our cooperators are big enterprises in China and well-known companies and labs abroad. Yacht has passed the ISO 9001 Q.C. certification, and all procedures are put in practice under Project Management Standards. Yacht has developed many high quality API products on the basis of abundant technology, advanced production technics and complete test measures. Meanwhile, Yacht strictly conforms to the ISO9001: 2000 quality system certification, regards technology as forerunner, accelerates the development of the new products with the technology, and always maintains and improves the quality of the products.
Chereso Lifesciences, incorporated in 2003, is a company dedicated to the principles
of tradition, innovation and research. The manufacturing is WHO-GMP, NSF- US GMP, ISO
9001:2008, ISO 22000:2005, Kosher and HALAL certified. The
Company's vision is to be a trusted healthcare provider, driven by excellence,
through innovation and quality.
Its business focuses on manufacturing of APIs, Nutraceuticals and standardized herbal extracts as per Pharmacopoeia Standards. The company is manufacturing a wide range of products supported with patents & clinically evaluated and is fast growing to meet the present and future market demands for plant-based scientifically processed products. Some of the major products of our company are Alpha Yohimbine, Colchicine, Thiocolchicosides, Sennosides, Fenugreek extract, Lysergol, Chlorogenic Acid, Protodioscin, Reserpine USB/BP among others. The company has expanded its business activities in countries like Asia, Africa, Europe, USA and other growing markets. For more information, please visit us at www.chereso.net, www.fenfuro.com
Chiracon has 20 years of experience in the field of drug synthesis and documentation. As a German, Berlin-Brandenburg based company the company can reliably offer all services possible in the field of synthetic drug development for new or generic products. We specialize in organic synthesis, scale up and production. Furthermore, we provide all the documentation needed for active pharmaceutical ingredients (APIs) for clinical trials, and also in order to introduce new APIs to market - ASMF (active substance master files) /DMF (drug master files), Pharmaceutical Quality/CMC (Chemistry, Manufacturing and Controls) /IMPD (Investigational Medicinal Product Dossier). We utilize a management system which is based on an integrated ISO9001 system and includes a GMP environment.
Carelife Pharmaceutical is a export-oriented high-tech enterprise in Chongqing with the manufacturing facilities of APIs and finished dosages in compliance with ICH and cGMP. The company is devoted to the development of the global market with 90% of its API products exporting to USA, Europe and Australia. It has established substantial cooperation with several transnational pharmaceutical companies enjoying international reputation in the field of pharmaceutical research & development and market exploitation.
We, Chromo laboratories India pvt Ltd are USFDA / EDQM / Mexican COFEPRIS Approved and GMP certified API manufacturers with several USDMFs, CEP ( Granted ) for our products. Our Intermediates Manufacturing Unit, GENSYNTH LABORATORIES PVT LTD is also a USFDA inspected Pharma Intermediates manufacturing unit and acts as a feeder plant for Chromo Lab's API unit. Our core strengths are Strict GMP and Regulatory compliance, Multi stage synthesis & Backward integration.
Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. Cobra has two GMP approved facilities in Sweden and the UK, each with specific expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market. As a trusted provider and a key partner in the drug development and commercialisation process, we take pride in our manufacturing excellence and comprehensive range of services to the pharmaceutical and biotech industries. Expertise Cobra is a Contract Development and Manufacturing Organisation (CDMO) supporting the global life sciences industry in the development and manufacture of proteins, DNA, viral vectors, microbiota and cell line derived products and pharmaceuticals for clinical trials and commercial supply. Experience 20 years of track record in producing biologics and pharmaceuticals for use in pre-clinical to Phase III clinical trials and commercial supply has given our people a unique knowledge base as both manufacturer and also as service providers for the global life sciences market. We offer a broad range of integrated and stand-alone development services, bespoke to individual customer requirements, stretching from cell line development to the supply of investigational medicinal product for clinical trials and commercial market supply. Excellence Every program complies with cGMP standards worldwide and is conceived with an unmatched quality derived from the know-how of Cobra's highly qualified, flexible and dedicated people. Cobra has two GMP approved facilities; in Sweden our Microbiota Production and Fill Finish Facility in Matfors and in the United Kingdom our Centre of Excellence for Gene Therapy, specialising in DNA and viral vector production, located in Keele. Our sites offer a comprehensive service to nurture your project from conception to fill and finish. Cobra takes pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients. For more information, or to get in touch with our team, visit: www.cobrabio.com
Contract Pharma is the international magazine for pharmaceutical and biopharmaceutical outsourcing. With over 20,000 BPA qualified subscribers, we offer a print and digital magazine, weekly e-newsletter, an annual company profile and contract services directory, an annual Conference and Exhibition and website with the latest breaking news. Stop by our stand for your FREE subscription today.
Coral Drugs is an integrated and independent research-based International Pharmaceutical Company that produces a diverse range of high-quality APIs and is headquartered in New Delhi, India. Our API focus covers several therapeutic areas and our facilities are approved by the USFDA, EUGMP and Indian regulatory agencies. At Coral, we believe in maintaining excellent quality standards for our products, services, and quality systems. Our commitment to customers is well-demonstrated by our ability to meet their customized demands and the availability of adequate product documentation such as product DMF's validations, and material/impurity standards. Products include: Active Pharmaceutical Ingredients, API custom manufacturing, Intermediates.
Corbion is a global biochemical ingredient company with a family of proven solutions based on renewable materials and resource-efficient processes that are, above all, safe for people to use and enjoy. Corbion is a new name, but can rely on more than 100 years of experience. We are built on the rich heritage of two successful companies that have been innovator's in the food and biochemical industry: Caravan Ingredients and Purac. We lead the way in sustainable practices through the use of renewable feedstocks and our rich heritage in natural lactic acid.
This forms the foundation for our biochemical applications in everything from (agro)chemicals, to resin adhesives, electronic components, pharmaceuticals, home care, personal care products and animal feed. In manufacturing we have a long history of excellence in sustainable and resource-efficient (fermentation-based) production processes across three key areas: organic acid, polymers, and emulsifiers. We do it, because we believe in the future. At Corbion our purpose is to improve the quality of life for people today and for generations to come. That means inspiring those around us to make a conscious choice in opting for safe, healthy and convenient solutions that benefit people, planet and profit. Afterall, we too are consumers of the product we co-create.We are committed to the biobased business. At Corbion we are looking beyond the here and now,creating ideas, formulas, ingredients and components that go far beyond customer expectations today.We truly believe that asking ourselves, ‘What now?' will lead to ‘What's next?'
Helping our customers solve the big challenges of their customers(the consumer) – is at the center of everything we do. In pharmaceuticals, patients are looking for safe and effective medicines. At Corbion we address these challenges by finding solutions to customers' most difficult questions and enabling them to widen their horizons through a toolbox of high-performance, safe and sustainable products and ingredients.
Dalian Sky Chemical Co., Ltd was founded in 2003, therefore we began in 1992. Company is mainly engaged in four categories of products: plant extracts, chemical raw materials, finished drug and API. Company only supply high-quality products along with perfect service and fair price to meet customer needs. Based on business development and international changes, the company is also registered with Hong Kong Sky Industry Group Ltd. We are sincerely willing to cooperate with the business elite around the world and create a better future together.
Dipharma is one of the leading European manufacturers of Active Pharmaceutical Ingredients, offering about 50 APIs with DMFs lodged worldwide. All three manufacturing sites have been successfully inspected by the European and US Authorities. A fully-equipped R&D Centre, supported by internal Intellectual Property department, develops innovative processes and crystalline forms. One dedicated pilot plant, one small production plant and suitable scale-up facilities make Dipharma the right partner for Custom Synthesis. Core technologies are: Nitration, Nitroesterfication, Complex Hydrogenations, Azidation, Chiral Synthesis, Organometallic, Grignard and Enzimatic chemistry.
Dongkook Pharmaceutical was founded in 1968 and since its foundation, Dongkook has concentrated on R&D and technology innovation. Dongkook is well known for OTC products of high brand values in Korea. Additionally, Dongkook has developed and produced outstanding therapeutic products including anesthetics, contrast media and anti-cancer agents. Dongkook has been recognized by domestic and foreign authorities for its quality of finished products, medical devices and APIs. Currently, Dongkook exports the finished products, medical devices and APIs to over 50 countries around the world, and seeks to grow into a global leading pharmaceutical company.
Ehfield works on Pharmaceuticals and Chemicals supply for above ten years . We have developed extensive connections with the global markets and accumulated good knowledge about market access to the international business. Our products are made in GMP ,ISO,Euro GMP, cGMP ,FDA ……approved facilities.
Innovation is the another main engine of our activities. We keep investing in research and development. Part research is oriented to the development of even more cost-reducing solutions.
We dedicate to develop a team spirit and hope our staff enjoy working together.
Ehfield sincerely believes that our clients' welfare is just our welfare ,our clients' developments and benefits are the prerequisite of our developments and benefits.
Enaltec was established in 2006 with the specific objective
to develop and produce niche and technology driven API at competitive prices through
its WHO GMP and US FDA approved sites and supply across the world. Enaltec has further strengthen its foothold in generic formulation
development through its R&D site Enaltec Pharma Research, having capacity to
develop wide range of dosage forms ranging from Solid oral, liquid oral, Derma,
Injectable, Potent molecule (Oncology and Hormones), Undertake cGMP analytical method
validation and registration ICH stability studies at Enaltec Formulation Labs.
ENALTEC= (API R&D + API Manufacturing) + (Formulation R&D [FFS/Turnkey])
Esteve Química has 50 years' experience developing, manufacturing and marketing oral and injectable-non-sterile grade API's (generic and NCE's for third-parties) for regulated markets. Our services include process and analytical development, scale-up, analytical transfer, validation, process optimization and commercial manufacturing, along with any required technical services. We offer particle engineering posibilites (micronization, spray-drying ...). We are regularly inspected by major Health Authorities (USA, Europe, Japan ...). Our cGMP's multipurpose plants (two in Spain (EQ Esteve), one in Mexico (Sintenovo) and one in China (EHP) have a total capacity in exess of 800m3 and clean room areas for the last steps of manufacturing.
EUCODIS Bioscience is an application-driven enzyme engineering and manufacturing company. We engineer enzymes using our proprietary gene shuffling and in-vivo recombination toolbox, which enables effective modification of target enzymes. We provide customized services in strain, bioprocess and DSP development as well as recombinant protein and enzyme production up to industrial-scale (under ISO 9001). In addition we offer high-performance enzymes for specific applications in biopharma, fine chemicals, cosmetics and other industries: >50 enzymes including beta-lactamases, lipases, peroxidases, phospholipases D, nitrile hydratases and others, which are selected because of specific properties, like chiral and regioselectivity, broader temperature and pH-profiles, among others.